REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
16/12/2020 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201216:nBw7W0ZgCa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
Ap19
FORM 8.3 Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 10 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,050,061 2.37% 690,622 0.54%
(2) Derivatives (other than options):
365,705 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,415,766 2.66% 1,429,627 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 207.4100 USD
Purchase 2 207.5537 USD
Purchase 4 206.7225 USD
Purchase 4 206.4300 USD
Purchase 7 207.1285 USD
Purchase 8 206.7062 USD
Purchase 9 206.9600 USD
Purchase 10 206.5320 USD
Purchase 10 206.8090 USD
Purchase 12 206.7500 USD
Purchase 12 207.2587 USD
Purchase 13 206.8530 USD
Purchase 14 207.0000 USD
Purchase 21 206.7766 USD
Purchase 24 205.9662 USD
Purchase 38 205.8800 USD
Purchase 49 205.8248 USD
Purchase 75 206.0933 USD
Purchase 192 206.7897 USD
Purchase 195 206.3376 USD
Purchase 227 205.7362 USD
Purchase 300 207.4256 USD
Purchase 388 206.2451 USD
Purchase 580 206.8575 USD
Purchase 786 205.9283 USD
Purchase 979 205.7588 USD
Purchase 1,223 206.8215 USD
Purchase 1,980 206.2361 USD
Purchase 2,477 206.0455 USD
Purchase 2,599 206.8174 USD
Purchase 2,660 206.7572 USD
Purchase 3,513 206.8200 USD
Purchase 3,582 207.0029 USD
Purchase 5,236 205.9211 USD
Purchase 7,777 207.0707 USD
Purchase 15,135 206.7458 USD
Purchase 23,472 206.5651 USD
Sale 1 206.3000 USD
Sale 1 206.9600 USD
Sale 1 206.8600 USD
Sale 1 206.7000 USD
Sale 2 206.3700 USD
Sale 2 206.8350 USD
Sale 6 207.1800 USD
Sale 6 206.9025 USD
Sale 7 206.4564 USD
Sale 9 206.6677 USD
Sale 10 206.8000 USD
Sale 20 207.2200 USD
Sale 42 206.5530 USD
Sale 44 206.5236 USD
Sale 100 207.6450 USD
Sale 106 207.5733 USD
Sale 200 206.8400 USD
Sale 205 205.9836 USD
Sale 240 207.5200 USD
Sale 287 206.5232 USD
Sale 306 206.0471 USD
Sale 329 207.0875 USD
Sale 507 206.2617 USD
Sale 600 206.9766 USD
Sale 827 206.3314 USD
Sale 889 206.2789 USD
Sale 914 206.2501 USD
Sale 1,014 206.4174 USD
Sale 1,111 206.7214 USD
Sale 1,333 206.8273 USD
Sale 2,237 206.3718 USD
Sale 2,598 206.8173 USD
Sale 3,498 206.8200 USD
Sale 3,623 206.4318 USD
Sale 4,647 206.7790 USD
Sale 5,936 206.8881 USD
Sale 9,725 206.8369 USD
Sale 10,000 205.9420 USD
Sale 11,214 206.7326 USD
Sale 11,669 206.7665 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 16 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201215006206/en/
(https://www.businesswire.com/news/home/20201215006206/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement